+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Key Starting Materials & Registered Starting Materials Market - Global Forecast 2026-2032- Product Image
Key Starting Materials & Registered Starting Materials Market - Global Forecast 2026-2032- Product Image
Sale

Key Starting Materials & Registered Starting Materials Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277493
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Starting Materials and Registered Starting Materials: Executive Overview

Key starting materials and registered starting materials support the controlled manufacture of active pharmaceutical ingredients and other regulated chemical products. Their importance is increasing as sponsors and manufacturers place greater emphasis on traceability, impurity control, supplier qualification, regulatory documentation, and continuity of supply. The market is shaped less by a single product category than by the interaction of chemistry capabilities, quality systems, registration obligations, and regional manufacturing resilience.

Regulatory Traceability and Supply Resilience Are Reshaping Procurement

Procurement is shifting from transactional sourcing toward documented, risk-based supplier management. Buyers increasingly evaluate change-control discipline, analytical methods, batch consistency, audit readiness, data integrity, and the ability to provide complete documentation across the material lifecycle. Dual sourcing, geographic diversification, inventory planning, and earlier technical engagement are also becoming central to managing disruptions involving logistics, energy, raw materials, trade controls, or facility capacity.

Artificial Intelligence Strengthens Quality, Planning, and Documentation Workflows

Artificial intelligence can improve starting-material operations by identifying anomalous batch data, prioritizing supplier risks, supporting demand and inventory planning, accelerating document review, and helping chemists assess synthetic routes and impurity risks. Its value is cumulative when connected to laboratory, enterprise-resource-planning, quality, and regulatory systems. However, AI-generated outputs require validated workflows, human oversight, controlled data access, and auditable decision records, particularly where material changes may affect regulatory filings or product quality.

Regional Differences Reflect Manufacturing Depth and Regulatory Coordination

North America emphasizes supply assurance, regulatory compliance, advanced manufacturing, and qualified domestic or near-shore sources. Latin America is shaped by import dependence, local registration requirements, logistics constraints, and opportunities to strengthen regional distribution and technical services. Europe combines mature quality expectations with strong chemical and pharmaceutical capabilities, while regulatory coordination and sustainability obligations influence supplier selection. The Middle East is developing pharmaceutical and chemical-production capacity and remains attentive to import resilience. Africa presents varied infrastructure and regulatory conditions, with opportunities centered on dependable distribution, quality systems, and local capability building. Asia-Pacific remains highly significant for chemical manufacturing, process development, and supplier networks, while customers increasingly distinguish among vendors by compliance maturity, transparency, and continuity planning.

Economic and Security Groups Influence Standards, Trade, and Supply-Chain Design

ASEAN markets offer interconnected manufacturing and trade routes but differ in regulatory maturity and technical capability. BRICS members span major chemical and pharmaceutical production centers alongside diverse policy and infrastructure environments, encouraging differentiated sourcing strategies. The European Union supports harmonized regulatory processes while maintaining demanding environmental, quality, and documentation expectations. G7 economies generally prioritize resilient supply chains, advanced quality systems, and strategic production capabilities. GCC countries are investing in industrial and pharmaceutical diversification, with procurement often linked to localization objectives. NATO members are increasingly attentive to critical-input resilience, cybersecurity, and continuity planning for strategically important supply chains.

Country Conditions Create Distinct Sourcing and Compliance Priorities

Australia combines strong regulatory expectations with reliance on international supply networks. Brazil offers substantial pharmaceutical demand and industrial potential, while import procedures and local requirements remain important. Canada emphasizes quality, compliance, and reliable cross-border supply. China provides broad chemical and process-manufacturing capabilities, but buyers must assess documentation, consistency, geopolitical exposure, and supplier transparency. France, Germany, Italy, Spain, and the United Kingdom reflect sophisticated pharmaceutical ecosystems with demanding quality, environmental, and regulatory requirements. India is a major source of pharmaceutical and chemical expertise, with supplier qualification and process consistency central to selection. Japan and South Korea emphasize advanced quality systems, technical precision, and dependable manufacturing. Mexico benefits from proximity to North American supply chains, while regulatory execution and logistics remain key considerations. Russia presents a complex operating environment affected by trade restrictions, logistics, and changing compliance conditions. The United States prioritizes validated quality systems, secure supply, regulatory readiness, and resilience across critical inputs.

Prioritize Qualified Dual Sourcing, Data Integrity, and Technical Collaboration

Industry leaders should segment starting materials by patient, regulatory, and operational criticality; qualify alternate suppliers before disruption occurs; and maintain documented change-control and contingency procedures. Supplier assessments should combine facility audits, analytical-data review, impurity-risk evaluation, cybersecurity checks, and evidence of business continuity. Organizations can improve responsiveness by connecting procurement, quality, technical operations, and regulatory teams early in development. AI should be deployed selectively for document triage, anomaly detection, and planning, with validation and human approval built into every consequential workflow. Regional sourcing decisions should also account for trade exposure, transport routes, environmental compliance, and the ability to support filings across jurisdictions.

Methodology: Evidence-Based Assessment of Supply, Quality, and Regulatory Factors

This executive summary uses the defined market scope of key starting materials and registered starting materials and organizes the assessment across regional, economic-group, and country dimensions. The analysis considers publicly verifiable regulatory expectations, pharmaceutical and chemical manufacturing capabilities, supplier-qualification practices, trade and logistics conditions, and documented technology trends. It intentionally excludes market estimates, market shares, forecasts, and company-specific claims. Interpretations should be validated against current national regulations, registration guidance, customs requirements, and audited supplier documentation before operational decisions are made.

Resilient Starting-Material Strategies Depend on Verified Quality and Regional Flexibility

The strategic importance of key starting materials and registered starting materials lies in their direct connection to product quality, regulatory continuity, and manufacturing reliability. Leaders that combine rigorous qualification with diversified supply, strong documentation, disciplined change control, and responsible use of AI will be better positioned to manage evolving requirements. A regional and country-sensitive approach is essential because manufacturing strengths, regulatory systems, logistics, and trade conditions vary materially across the global supply network.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Key Starting Materials & Registered Starting Materials Market, by Material Classification
7.1. Introduction
7.2. Key Starting Materials
7.2.1. Advanced Intermediates
7.2.2. Chiral Building Blocks
7.2.3. Halogenated Intermediates
7.2.4. Heterocyclic Intermediates
7.2.5. Primary Intermediates
7.3. Registered Starting Materials
7.3.1. Biologics RSM
7.3.1.1. Master and Working Cell Banks
7.3.1.2. Plasmids and Expression Vectors
7.3.1.3. Viral Seeds
7.3.2. Oligonucleotide RSM
7.3.2.1. Capping and Activator Reagents
7.3.2.2. Phosphoramidites
7.3.2.3. Solid Supports
7.3.3. Peptide RSM
7.3.3.1. Fmoc/Boc Amino Acid Derivatives
7.3.3.2. Linkers and Resins
7.3.4. Small Molecule RSM
8. Key Starting Materials & Registered Starting Materials Market, by Molecular Class
8.1. Introduction
8.2. Carbohydrates and Glycans
8.3. Complex Small Molecule
8.3.1. Carbohydrates
8.3.2. Steroids
8.3.3. Terpenes
8.4. Lipids
8.4.1. Cholesterol Derivatives
8.4.2. Ionizable Lipids
8.4.3. Phospholipids
8.5. Oligonucleotides
8.5.1. ASO/siRNA Precursors
8.5.2. DNA
8.5.3. RNA
8.6. Peptides
8.6.1. Cyclic Peptides
8.6.2. Linear Peptides
8.7. Polymers and PEG Derivatives
8.8. Small Molecule
8.8.1. Aliphatic
8.8.2. Aromatic
8.8.3. Organometallic
9. Key Starting Materials & Registered Starting Materials Market, by Product Form
9.1. Introduction
9.2. Gas
9.3. Liquid
9.4. Solid
9.4.1. Amorphous
9.4.2. Crystalline
9.4.3. Polymorph-Controlled
10. Key Starting Materials & Registered Starting Materials Market, by Application Area
10.1. Introduction
10.2. Dosage Form Compatibility
10.2.1. Inhalation
10.2.2. Ophthalmic
10.2.3. Oral Solid Dose
10.2.4. Parenteral/Injectable
10.2.5. Topical
10.2.6. Transdermal
10.3. Therapeutic Area
10.3.1. Anti-Infectives
10.3.2. Cardiovascular
10.3.3. Central Nervous System
10.3.4. Dermatology
10.3.5. Metabolic and Endocrine
10.3.6. Oncology
10.3.7. Ophthalmology
10.3.8. Rare Diseases
10.3.9. Respiratory
11. Key Starting Materials & Registered Starting Materials Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Key Starting Materials & Registered Starting Materials Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Key Starting Materials & Registered Starting Materials Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Aarti Industries Limited
15.2. Alkem Laboratories Limited
15.3. Aurobindo Pharma Limited
15.4. Cambrex Corporation
15.5. Cipla Limited
15.6. Dishman Carbogen Amcis Ltd.
15.7. Divi's Laboratories Limited
15.8. Dr. Reddy's Laboratories Limited
15.9. Evonik Industries AG
15.10. Glenmark Pharmaceuticals Limited
15.11. IPCA Laboratories Limited
15.12. Jubilant Biosys Limited
15.13. Jubilant Pharmova Limited
15.14. Laurus Labs Limited
15.15. Merck & Co., Inc.
15.16. Pfizer Inc.
15.17. Piramal Pharma Limited
15.18. Sun Pharmaceutical Industries Limited
15.19. Syngene International Limited
15.20. Teva Pharmaceutical Industries Ltd.
15.21. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Key Starting Materials & Registered Starting Materials Market, Years Considered for the Study
FIGURE 2. Global Key Starting Materials & Registered Starting Materials Market, Research Design
FIGURE 3. Global Key Starting Materials & Registered Starting Materials Market, Research Framework
FIGURE 4. Global Key Starting Materials & Registered Starting Materials Market, Data Triangulation
FIGURE 5. Global Key Starting Materials & Registered Starting Materials Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2025 vs 2032 (%)
FIGURE 7. Global Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2025 vs 2032 (%)
FIGURE 9. Global Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 11. Global Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2025 vs 2032 (%)
FIGURE 13. Global Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Key Starting Materials & Registered Starting Materials Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Key Starting Materials & Registered Starting Materials Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Key Starting Materials & Registered Starting Materials Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Key Starting Materials & Registered Starting Materials Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Key Starting Materials & Registered Starting Materials Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Key Starting Materials & Registered Starting Materials Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Key Starting Materials & Registered Starting Materials Market Segmentation & Coverage
TABLE 2. Global Key Starting Materials & Registered Starting Materials Market Size, 2017-2032 (USD Million)
TABLE 3. Global Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 4. Global Key Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Key Starting Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Key Starting Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Advanced Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Advanced Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Advanced Intermediates Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Chiral Building Blocks Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Chiral Building Blocks Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Chiral Building Blocks Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Halogenated Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Halogenated Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Halogenated Intermediates Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Heterocyclic Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Heterocyclic Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Heterocyclic Intermediates Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Primary Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Primary Intermediates Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Primary Intermediates Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Registered Starting Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Registered Starting Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Biologics RSM Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Biologics RSM Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Biologics RSM Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Master and Working Cell Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Master and Working Cell Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Master and Working Cell Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Plasmids and Expression Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Plasmids and Expression Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Plasmids and Expression Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Viral Seeds Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Viral Seeds Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Viral Seeds Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Oligonucleotide RSM Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Oligonucleotide RSM Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Oligonucleotide RSM Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Capping and Activator Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Capping and Activator Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Capping and Activator Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Phosphoramidites Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Phosphoramidites Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Phosphoramidites Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Solid Supports Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Solid Supports Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Solid Supports Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Peptide RSM Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Peptide RSM Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Peptide RSM Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Fmoc/Boc Amino Acid Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Fmoc/Boc Amino Acid Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Fmoc/Boc Amino Acid Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Linkers and Resins Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Linkers and Resins Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Linkers and Resins Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Small Molecule RSM Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Small Molecule RSM Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Small Molecule RSM Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 62. Global Carbohydrates and Glycans Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Carbohydrates and Glycans Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Carbohydrates and Glycans Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Complex Small Molecule Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Complex Small Molecule Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Complex Small Molecule Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Carbohydrates Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Carbohydrates Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Carbohydrates Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Steroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Steroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Steroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Terpenes Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Terpenes Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Terpenes Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Lipids Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Lipids Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Lipids Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Cholesterol Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Cholesterol Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Cholesterol Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Ionizable Lipids Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Ionizable Lipids Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Ionizable Lipids Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Phospholipids Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Phospholipids Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Phospholipids Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global ASO/siRNA Precursors Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global ASO/siRNA Precursors Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global ASO/siRNA Precursors Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Cyclic Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Linear Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Linear Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Linear Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Polymers and PEG Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Polymers and PEG Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Polymers and PEG Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Small Molecule Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Small Molecule Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Small Molecule Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Aliphatic Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Aliphatic Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Aliphatic Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Aromatic Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Aromatic Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Aromatic Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Organometallic Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Organometallic Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Organometallic Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 126. Global Gas Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Gas Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Gas Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Solid Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Solid Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Solid Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Amorphous Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Amorphous Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Amorphous Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Crystalline Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Crystalline Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Crystalline Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Polymorph-Controlled Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Polymorph-Controlled Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Polymorph-Controlled Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 145. Global Dosage Form Compatibility Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Dosage Form Compatibility Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Dosage Form Compatibility Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Oral Solid Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Oral Solid Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Oral Solid Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Parenteral/Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Parenteral/Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Parenteral/Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Transdermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Transdermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Transdermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Therapeutic Area Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Therapeutic Area Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Therapeutic Area Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Anti-Infectives Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Anti-Infectives Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Anti-Infectives Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Central Nervous System Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Central Nervous System Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Central Nervous System Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Dermatology Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Dermatology Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Dermatology Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Metabolic and Endocrine Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Metabolic and Endocrine Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Metabolic and Endocrine Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Ophthalmology Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Rare Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Rare Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Rare Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 210. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 211. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Solid, 2017-2032 (USD Million)
TABLE 212. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 213. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Dosage Form Compatibility, 2017-2032 (USD Million)
TABLE 214. Asia-Pacific Key Starting Materials & Registered Starting Materials Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 215. North America Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. North America Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 217. North America Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 218. North America Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 219. North America Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 220. North America Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 221. North America Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 222. North America Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 223. North America Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 224. North America Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 225. North America Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 226. North America Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 227. North America Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 228. North America Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 229. North America Key Starting Materials & Registered Starting Materials Market Size, by Solid, 2017-2032 (USD Million)
TABLE 230. North America Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 231. North America Key Starting Materials & Registered Starting Materials Market Size, by Dosage Form Compatibility, 2017-2032 (USD Million)
TABLE 232. North America Key Starting Materials & Registered Starting Materials Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 233. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 235. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 236. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 237. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 238. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 239. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 240. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 241. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 242. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 243. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 244. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 245. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 246. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 247. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Solid, 2017-2032 (USD Million)
TABLE 248. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 249. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Dosage Form Compatibility, 2017-2032 (USD Million)
TABLE 250. Latin America Key Starting Materials & Registered Starting Materials Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 251. Europe Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Europe Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 253. Europe Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 254. Europe Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 255. Europe Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 256. Europe Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 257. Europe Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 258. Europe Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 259. Europe Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 260. Europe Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 261. Europe Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 262. Europe Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 263. Europe Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 264. Europe Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 265. Europe Key Starting Materials & Registered Starting Materials Market Size, by Solid, 2017-2032 (USD Million)
TABLE 266. Europe Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 267. Europe Key Starting Materials & Registered Starting Materials Market Size, by Dosage Form Compatibility, 2017-2032 (USD Million)
TABLE 268. Europe Key Starting Materials & Registered Starting Materials Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 269. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 270. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 271. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 272. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 273. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 274. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 275. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 276. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 277. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 278. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 279. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 280. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 281. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 282. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 283. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Solid, 2017-2032 (USD Million)
TABLE 284. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 285. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Dosage Form Compatibility, 2017-2032 (USD Million)
TABLE 286. Middle East Key Starting Materials & Registered Starting Materials Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 287. Africa Key Starting Materials & Registered Starting Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 288. Africa Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 289. Africa Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 290. Africa Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 291. Africa Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 292. Africa Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 293. Africa Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 294. Africa Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 295. Africa Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 296. Africa Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 297. Africa Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 298. Africa Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 299. Africa Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 300. Africa Key Starting Materials & Registered Starting Materials Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 301. Africa Key Starting Materials & Registered Starting Materials Market Size, by Solid, 2017-2032 (USD Million)
TABLE 302. Africa Key Starting Materials & Registered Starting Materials Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 303. Africa Key Starting Materials & Registered Starting Materials Market Size, by Dosage Form Compatibility, 2017-2032 (USD Million)
TABLE 304. Africa Key Starting Materials & Registered Starting Materials Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 305. Global Key Starting Materials & Registered Starting Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 307. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Material Classification, 2017-2032 (USD Million)
TABLE 308. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Key Starting Materials, 2017-2032 (USD Million)
TABLE 309. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Registered Starting Materials, 2017-2032 (USD Million)
TABLE 310. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Biologics RSM, 2017-2032 (USD Million)
TABLE 311. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotide RSM, 2017-2032 (USD Million)
TABLE 312. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Peptide RSM, 2017-2032 (USD Million)
TABLE 313. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Molecular Class, 2017-2032 (USD Million)
TABLE 314. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Complex Small Molecule, 2017-2032 (USD Million)
TABLE 315. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Lipids, 2017-2032 (USD Million)
TABLE 316. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Oligonucleotides, 2017-2032 (USD Million)
TABLE 317. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 318. ASEAN Key Starting Materials & Registered Starting Materials Market Size, by Small Molecule, 2017-2032 (USD Million)
TABLE 319. ASEAN Key Sta

Companies Mentioned

  • Aarti Industries Limited
  • Alkem Laboratories Limited
  • Aurobindo Pharma Limited
  • Cambrex Corporation
  • Cipla Limited
  • Dishman Carbogen Amcis Ltd.
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories Limited
  • Evonik Industries AG
  • Glenmark Pharmaceuticals Limited
  • IPCA Laboratories Limited
  • Jubilant Biosys Limited
  • Jubilant Pharmova Limited
  • Laurus Labs Limited
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Piramal Pharma Limited
  • Sun Pharmaceutical Industries Limited
  • Syngene International Limited
  • Teva Pharmaceutical Industries Ltd.
  • WuXi AppTec Co., Ltd.

Related Reports

Key Starting Materials Market - Global Forecast 2026-2032 - Product Image

Key Starting Materials Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Swimming Starting Blocks Market - Global Forecast 2026-2032 - Product Image

Swimming Starting Blocks Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Track Starting Blocks Market - Global Forecast 2026-2032 - Product Image

Track Starting Blocks Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Starting Lighting Ignition Batteries Market - Global Forecast 2026-2032 - Product Image

Starting Lighting Ignition Batteries Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Lead Acid Battery for Starting Market - Global Forecast 2026-2032 - Product Image

Lead Acid Battery for Starting Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.